Tirabrutinib is under investigation in clinical trial NCT02626026 (Safety and Pharmacokinetics of GS-4059 in Healthy Volunteers and Subjects With Rheumatoid Arthritis (RA)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.